Tomoyuki Miyazaki Selected Research

Tomoyuki Miyazaki Research Topics

Disease

4	Epilepsy (Aura) 01/2023 - 01/2020
3	Schizophrenia (Dementia Praecox) 01/2024 - 10/2016
2	Mental Disorders (Mental Disorder) 01/2024 - 01/2022
2	Infections 02/2022 - 01/2021
2	Temporal Lobe Epilepsy 01/2022 - 01/2020
2	COVID-19 01/2021 - 01/2021
2	Neuralgia (Stump Neuralgia) 02/2014 - 01/2011
2	Hyperalgesia 02/2014 - 01/2011
1	Catalepsy 01/2024
1	Parkinsonian Disorders (Parkinsonism) 01/2024
1	Hypertension (High Blood Pressure) 10/2023
1	Glioblastoma (Glioblastoma Multiforme) 10/2023
1	Neoplasms (Cancer) 10/2023
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2023
1	Parkinson Disease (Parkinson's Disease) 01/2023
1	Ocular Albinism 01/2023
1	Pulmonary Hypertension 02/2022
1	Cognitive Dysfunction 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Partial Epilepsies (Epilepsy, Partial) 01/2022
1	Amyloidosis 01/2022
1	Fever (Fevers) 01/2021
1	Ureteral Obstruction 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Alcoholism (Alcohol Abuse) 01/2019
1	AIDS-Related Complex (ARC) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2014
1	Hypersensitivity (Allergy) 02/2014
1	Peripheral Nerve Injuries 01/2011

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2011
3	AMPA Receptors (AMPA Receptor)IBA 01/2023 - 01/2020
2	levodopa receptorIBA 01/2024 - 02/2022
2	Levodopa (L Dopa)FDA LinkGeneric 01/2024 - 01/2023
2	propionic acid (potassium propionate)IBA 10/2023 - 01/2022
2	Therapeutic UsesIBA 01/2023 - 01/2020
2	Sevoflurane (Ultane)FDA LinkGeneric 01/2023 - 01/2022
2	Neutralizing AntibodiesIBA 02/2022 - 01/2021
2	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2022 - 01/2022
2	AntigensIBA 01/2021 - 01/2021
1	Haloperidol (Haldol)FDA LinkGeneric 01/2024
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2024
1	Antipsychotic Agents (Antipsychotics)IBA 01/2024
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2024
1	Cholinergic Agents (Cholinergics)IBA 01/2024
1	Angiotensin IIIBA 10/2023
1	Type 1 Angiotensin ReceptorIBA 10/2023
1	Hormones (Hormone)IBA 10/2023
1	perampanelIBA 10/2023
1	Glutamic Acid (Glutamate)FDA Link 10/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2023
1	Amino Acids FDA Link 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	MonocrotalineIBA 02/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Propofol (Diprivan)FDA LinkGeneric 01/2022
1	AcidsIBA 01/2022
1	Halothane (Fluothane)FDA Link 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Isoflurane FDA LinkGeneric 01/2022
1	Nucleocapsid ProteinsIBA 01/2021
1	AntibodiesIBA 01/2021
1	GhrelinIBA 01/2020
1	liu-jun-zi-tangIBA 01/2020
1	Cocaine (Cocaine HCl)IBA 01/2019
1	Heroin (Diamorphine)IBA 01/2019
1	ProlactinIBA 01/2018
1	Methamphetamine (Desoxyn)FDA LinkGeneric 10/2016
1	staurosporine aglycone (K252a)IBA 02/2014
1	Nerve Growth Factors (Neurotrophins)IBA 02/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2014
1	Nerve Growth Factor (NGF)IBA 02/2014
1	Semaphorin-3AIBA 01/2011

Therapy/Procedure

2	Anesthesia 01/2023 - 01/2022
1	Electrodes (Electrode) 01/2022
1	Extracorporeal Membrane Oxygenation 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021